Neil Robertson
Overview
Explore the profile of Neil Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
7686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Griffiths L, Hawkins K, Yutuc E, Angelini R, Fosuah R, Pacciarini M, et al.
Brain Pathol
. 2025 Mar;
:e70001.
PMID: 40045480
Disability worsening in multiple sclerosis (MS) is linked to neurodegeneration. Cholesterol homeostasis is essential for normal brain function. CYP46A1, crucial for brain cholesterol turnover and reduced in some neurodegenerative diseases,...
2.
Arun T, Petheram K, Tallantyre E, Ford H, Chataway J, Dougall N, et al.
Mult Scler Relat Disord
. 2024 Nov;
92:106144.
PMID: 39579643
Therapeutics of neuroinflammatory disorders including multiple sclerosis is one of the fastest growing areas in neurology. However, pressures on higher specialty training in neurology together with an expanding curriculum have...
3.
Blackstone J, Williams T, Nicholas J, Bordea E, De Angelis F, Bianchi A, et al.
BMJ Open
. 2024 Sep;
14(9):e086414.
PMID: 39284697
Introduction: There remains a high unmet need for disease-modifying therapies that can impact disability progression in secondary progressive multiple sclerosis (SPMS). Following positive results of the phase 2 MS-STAT study,...
4.
5.
Kalluvettukuzhy N, Maciejczyk M, Robertson N
Phys Chem Chem Phys
. 2024 Jun;
26(26):18129-18137.
PMID: 38896039
We demonstrate for the first time a unique approach to efficiently sensitize lanthanides(III) using photosensitizer ligands that show thermally activated delayed fluorescence (TADF). TADF ligands have very small singlet (S)...
6.
Nicholas R, Tallantyre E, Witts J, Marrie R, Craig E, Knowles S, et al.
J Neurol Neurosurg Psychiatry
. 2024 May;
95(11):1032-1035.
PMID: 38782573
Background: Identification of multiple sclerosis (MS) cases in routine healthcare data repositories remains challenging. MS can have a protracted diagnostic process and is rarely identified as a primary reason for...
7.
Nasir M, Hone L, Tallantyre E, Kelly P, Leite M, Robertson N, et al.
Mult Scler Relat Disord
. 2024 Mar;
85:105528.
PMID: 38479046
Background: Aquaporin-4 (AQP4) antibody associated neuromyelitis optica (NMOSD) requires long-term immunosuppression. Rituximab is increasingly used worldwide, however the optimal regime is not established. Methods: We retrospectively examined different rituximab regimens...
8.
Suizu R, Shuku Y, Robert V, Roseiro P, Ben Amor N, Khawar Z, et al.
Dalton Trans
. 2023 Dec;
53(5):1961-1965.
PMID: 38099702
Galvinoxyl, as one of the most extensively studied organic stable free radicals, exhibits a notable phase transition from a high-temperature (HT) phase with a ferromagnetic (FM) intermolecular interaction to a...
9.
Barbosa K, Deshpande A, Perales M, Xiang P, Murad R, Pramod A, et al.
Blood
. 2023 Dec;
143(8):697-712.
PMID: 38048593
Aberrant expression of stem cell-associated genes is a common feature in acute myeloid leukemia (AML) and is linked to leukemic self-renewal and therapy resistance. Using AF10-rearranged leukemia as a prototypical...
10.
Chen M, Kim B, Robertson N, Mondal S, Medarova Z, Moore A
Front Mol Biosci
. 2023 Jul;
10:1179343.
PMID: 37398551
Recent studies have shown that miRNA-10b is highly expressed in high-grade glioblastoma multiforme (GBM), and its inhibition leads to deregulation of multiple pathways in tumorigenesis, resulting in repression of tumor...